Icade, FR0000035081

Icade refines healthcare strategy, French real estate shares stay in focus

25.06.2026 - 15:12:00 | ad-hoc-news.de

Icade highlights its healthcare and office real estate repositioning while investors track the Paris-listed shares within the European property sector.

Icade, FR0000035081
Icade, FR0000035081

By Thomas Klein, Operations & Strategy desk. Reviewed prior to publication on 2026-06-25, 15:11.

Icade (FR0000035081) remains a mid-cap name in the French listed real estate universe. The stock trades in Paris within the property segment, alongside peers such as Unibail-Rodamco-Westfield and Gecina on Euronext Paris.

Shift toward healthcare assets

Icade presents itself as a major player in commercial real estate in France, with a particular emphasis on healthcare and office assets according to its corporate information. The company highlights a portfolio that includes clinics, medical centers and business parks serving tenants across the country.Icade Investor Relations overview

The group underscores its strategy of focusing on resilient segments such as healthcare-related properties, which tend to be backed by long-term leases with specialized operators. This positioning differentiates Icade from more retail-oriented landlords in Europe, where structural shifts in consumer behavior have pressured rents in certain formats.Reuters commentary on European real estate

Operations and portfolio management

Icade details recurring rental income as a central performance metric, derived from a mix of healthcare, office and other commercial properties. The company manages its portfolio actively, disposing of non-core assets and reinvesting in segments where demand and occupancy appear robust based on disclosed strategy presentations.Icade strategy and publications

Within the European property sector, listed landlords have responded to higher funding costs by revisiting development pipelines and capital allocation. Icade’s focus on stabilized healthcare properties aligns with a broader industry tendency to prioritize assets with predictable cash flows when interest rates are elevated compared with the past decade.Financial Times analysis of property REIT strategies

Go deeper

Background and price data on Icade

More company news, historical quotes and key figures on the Icade shares are available on the dedicated topic page and the group’s Investor Relations section.

What the company sells

Icade’s business model centers on owning, developing and managing healthcare facilities and office buildings, generating rental income from tenants. A representative segment is its portfolio of clinics and medical centers, which illustrates the group’s emphasis on healthcare real estate in France.Icade healthcare real estate segment

Where the stock trades today

The Icade shares (FR0000035081) trade on Euronext Paris, with the most recently verifiable quote available through the Paris exchange and major financial data providers, stated in euros.

Key data on the Icade shares

  • Company: Icade S.A.
  • ISIN: FR0000035081
  • WKN: 402641
  • Ticker: ICAD
  • Trading venue: Euronext Paris
  • Price (as of 2026-06-25, 13:00): 40.50 EUR
  • Market cap: 3.30 billion EUR (as of 2026-06-25)
  • Sector / industry: Real Estate Investment & Services
  • Index membership: SBF 120
  • Next earnings date: not officially scheduled

More on the Icade shares in social media

Disclaimer: This article is for informational purposes only and does not constitute investment advice, a recommendation or an offer to buy or sell securities. All data are based on sources deemed reliable but cannot be guaranteed for accuracy or completeness.

en | FR0000035081 | ICADE | boerse | 69624119 | bgmi